ESG Report 2021

Major R&D Pipeline Product R&D stage 18 Environmental, Social and Governance Report 2021 The United Laboratories International Holdings Limited Indications： Diabetes Diabetes & Obesity Eczema &Asthma Rheumatoid Arthritis Xerophthalmia Conjunctivitis Atopic Dermatitis Inflammatory Bowel Disease Dermatosis R&D Stages： Production registration Clinical trial Clinical registration Preclinical Polyvinyl Alcohol Eye Drops Sodium Hyaluronate Eye Drops Moxifloxacin Eye Drops LB2002 LB2101 Mupirocin Ointment WXSH0150 LB1091 Anti-IL-4R monoclonal antibody Osteoporosis Monoclonal Antibody Anti-osteoporosis Peptides Liraglutide Injection Insulin Degludec Injection Insulin Degludec/Liraglutide Insulin Degludec/Insulin Aspart GLP-1 Oral Preparation Ultra-long-acting Insulin analogue Semaglutide Injection Second-generation Gastrointestinal Hormones Gastrointestinal Hormones Dual Target Hypolipidemic drugs Osteoporosis Hyperlipidemia